Beclomethasone Dipropionate
USP/EP/BP grade glucocorticoid supplied in micronized form for MDI, DPI, and nasal spray manufacturing. Sourced for asthma prophylaxis, allergic rhinitis, and topical dermatological formulation lines.
Pharmaceutical & Life Science Solutions
Synthetic glucocorticoid APIs spanning topical, inhaled, injectable, and systemic formulation grades. Supplied in USP/EP/BP specification to pharmaceutical manufacturers across regulated and emerging export markets.
USP/EP/BP grade glucocorticoid supplied in micronized form for MDI, DPI, and nasal spray manufacturing. Sourced for asthma prophylaxis, allergic rhinitis, and topical dermatological formulation lines.
Long-acting glucocorticoid available as free base, dipropionate (5593-20-4), valerate (2152-44-5), and sodium phosphate (151-73-5) — USP/EP/BP grade. Supplied for topical, injectable, and antenatal corticosteroid formulation manufacturing.
Corticosteroid API for topical anti-inflammatory formulations. Supplied to specification for cream, ointment, and emollient manufacturing. CAS to be confirmed against supplier CoA — related compounds include Clobetasol Propionate (25122-41-2) and Clobetasone Butyrate (25122-57-0).
Mid-potency fluorinated corticosteroid in USP/EP/BP grade for topical, otic, and ophthalmic formulation manufacturing. Exported for dermatitis, psoriasis, eczema, and otitis externa therapeutic product lines.
Natural corticosteroid supplied as free base (50-23-7) and acetate ester (50-03-3) — USP/EP/BP grade — for oral tablet, topical cream, suppository, and injectable depot formulation manufacturing across adrenal and inflammatory indications.
Water-soluble injectable corticosteroid API in USP/EP grade for lyophilised powder-for-injection manufacturing. Sourced for emergency IV/IM protocols — anaphylaxis, acute adrenal crisis, and severe inflammatory episodes.
Synthetic glucocorticoid supplied as oral-grade base (83-43-2) and depot-injectable acetate ester (53-36-1) — USP/EP/BP grade. Exported for tablet, intra-articular suspension, and IM depot formulation lines in rheumatological and autoimmune indications.
High-potency water-soluble IV corticosteroid in USP/EP grade for lyophilised powder-for-injection manufacturing. Sourced for pulse therapy in acute spinal cord injury, transplant rejection prophylaxis, and severe asthma protocols.
High-potency non-halogenated glucocorticoid in USP/EP/BP grade for nasal spray, dry powder inhaler, and topical formulation manufacturing. Exported for allergic rhinitis, persistent asthma, and dermatological treatment product lines.
Versatile synthetic glucocorticoid supplied as oral-grade base (50-24-8) and ophthalmic-grade acetate (52-21-1) — USP/EP/BP. Exported for tablet, syrup, and ophthalmic suspension formulations across inflammatory, autoimmune, and ocular indications.
Fluorinated corticosteroid supplied as free base (124-94-7) and acetonide ester (76-25-5) — USP/EP/BP grade — for topical, intra-articular injectable, nasal spray, and inhaled formulation manufacturing across dermatological, rheumatological, and respiratory indications.